Search
forResearch 2 of 19
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →